The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSkinbiotherap. Regulatory News (SBTX)

Share Price Information for Skinbiotherap. (SBTX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10.00
Bid: 9.50
Ask: 10.50
Change: 0.00 (0.00%)
Spread: 1.00 (10.526%)
Open: 10.15
High: 10.15
Low: 9.75
Prev. Close: 10.00
SBTX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

23 May 2017 15:21

RNS Number : 0104G
SkinBioTherapeutics PLC
23 May 2017
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

SkinBioTherapeutics

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

NO

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

YES

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

NO

An event changing the breakdown of voting rights

NO

Other (please specify):

3. Full name of person(s) subject to thenotification obligation: iii

SPREADEX LTD

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

15/05/2017

6. Date on which issuer notified:

23/05/2017

7. Threshold(s) that is/are crossed orreached: vi, vii

>3%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 1 -

3,233,333

3,233,333

3,233,333

3,233,333

2.72%

GB00BF33H870

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

CFD/SPREADBET

349,778

0.30%

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

3,583,111

3.02%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will ceaseto hold:

12. Date on which proxy holder will cease to holdvoting rights:

13. Additional information:

14. Contact name:

DAVID CORBEN

15. Contact telephone number:

01727 895135

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLAJMITMBBTBPR
Date   Source Headline
4th Dec 20207:00 amRNSFinal Results
2nd Dec 202011:16 amRNSNotice of Results
2nd Nov 20204:15 pmRNSHolding(s) in Company
2nd Nov 20203:49 pmRNSHolding(s) in Company
30th Oct 202012:23 pmRNSResult of General Meeting and Open Offer
14th Oct 20207:00 amRNSPlacing and Open Offer
18th Sep 20204:48 pmRNSGrant of Options
8th Sep 20207:19 amRNSAppointment of Senior Medical Advisor
31st Jul 20207:00 amRNSProduct Development Progress
7th Jul 20207:00 amRNSBusiness Update
26th Jun 20207:00 amRNSChange of Adviser
23rd Jun 20204:29 pmRNSHolding(s) in Company
1st Jun 20203:45 pmRNSHolding(s) in Company
17th Apr 20204:24 pmRNSHolding(s) in Company
17th Mar 20204:42 pmRNSSecond Price Monitoring Extn
17th Mar 20204:38 pmRNSPrice Monitoring Extension
3rd Mar 20207:00 amRNSHalf Year Results
19th Feb 20207:00 amRNSAgreement signed with Winclove Probiotics B.V.
19th Dec 201911:47 amRNSResult of AGM
26th Nov 20198:50 amRNSNotice of AGM
26th Nov 20197:00 amRNSFinal Results
20th Nov 20197:00 amRNSCommercial Agreement
6th Nov 201910:38 amRNSHolding(s) in Company
28th Aug 20192:05 pmRNSSecond Price Monitoring Extn
28th Aug 20192:00 pmRNSPrice Monitoring Extension
28th Aug 20197:00 amRNSHolding(s) in Company
4th Jul 20197:00 amRNSBusiness Update and Board Changes
18th Apr 20197:00 amRNSDirector Appointment
16th Apr 20197:00 amRNSDirector/PDMR Shareholding
8th Apr 20197:00 amRNSSkinBiotix shows efficacy in first human study
29th Mar 20197:00 amRNSCEO Designate Appointment
18th Feb 20197:00 amRNSIssue of Equity
14th Feb 20197:00 amRNSHalf year results
1st Feb 20193:30 pmRNSAppointment of Joint Broker
31st Jan 20198:35 amRNSUpdate on human study and IP portfolio extension
31st Jan 20197:00 amRNSUpdate on human studies & IP portfolio extension
20th Nov 20187:00 amRNSCommencement of final phase of human studies
19th Nov 201812:30 pmRNSResult of AGM
7th Nov 20187:00 amRNSSkinBiotix® generates positive data in human study
25th Oct 20187:00 amRNSFull year results
19th Sep 20187:00 amRNSHuman study commenced
18th Sep 20182:05 pmRNSSecond Price Monitoring Extn
18th Sep 20182:00 pmRNSPrice Monitoring Extension
3rd Sep 20187:00 amRNSSkinBiotix technology successful in stability test
16th Aug 201811:05 amRNSSecond Price Monitoring Extn
16th Aug 201811:00 amRNSPrice Monitoring Extension
16th Aug 20187:00 amRNSBusiness Update
3rd Aug 20188:57 amRNSHolding(s) in Company
23rd Jul 20181:13 pmRNSHolding(s) in Company
18th Jul 20187:00 amRNSProvisional ethics approval for human study

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.